Exosome precipitation from
Plasma and Serum |
EPStep-PS |
ImmunoStep |
5 ml |
EUR 356.4 |
Dog Serum Laboratories manufactures the dig favce sirum reagents distributed by Genprice. The Dig Favce Sirum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Dog Serum. Other Dig products are available in stock. Specificity: Dig Category: Favce Group: Sirum
Exosome precipitation from
Plasma and Serum |
ImmunoStep |
5 ml |
EUR 356.4 |
Blood and Serum DNA Isolation Kit |
Biochain |
1 kit |
EUR 355 |
Sirum information
Anti-Dig. Coated Mag. Particles |
DIGMS-20-2 |
Spherotech |
2 mL |
EUR 372 |
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone. |
Anti-Dig. Coated Mag. Particles |
DIGMS-40-2 |
Spherotech |
2 mL |
EUR 372 |
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone. |
Anti-IL6 (Sirukumab)-MC-MMAF ADC |
ADC-W-1408 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC linker to MMAF |
Anti-IL6 (Sirukumab)-SMCC-DM1 ADC |
ADC-W-1406 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a SMCC linker to DM1 |
Anti-IL6 (Sirukumab)-SPDB-DM4 ADC |
ADC-W-1407 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a SPDB linker to DM4 |
Anti-IL6 (Sirukumab)-MC-Vc-PAB-MMAE ADC |
ADC-W-1409 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc linker to MMAE |
Anti-IL6 (Sirukumab)-MC-Vc-PAB-SN38 ADC |
ADC-W-1410 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc-PAB linker to SN38 |
Anti-IL6 (Sirukumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC |
ADC-W-1411 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA |
Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204) |
VAng-Cr4195-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4200 |
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein. |
Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204) |
VAng-Cr4195-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2997.6 |
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein. |
Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204) |
VAng-Cr4195-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2040 |
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein. |
Favipiravir |
10-027 |
ProSci |
100 mg |
EUR 440.88 |
Description: The guanine analog Favipiravir is a broad spectrum inhibitor of viral RNA polymerase, acting on viral genetic copying to prevent its reproduction. Favipiravir is a prodrug that is metabolized to its active form, favipiravir-ribofuranosyl-5'-triphosphate (Favipiravir-RTP), which inhibits selectively RNA-dependent RNA polymerase (RdRp) in RNA viruses. This antiviral agent inhibits influenza A, B and C without inducing cytotoxicity up to 1,000 µg/ml. It also inhibits influenza strains resistant to current antiviral drugs and shows a synergistic effect in combination with oseltamivir (Prod. No. AG-CR1-3714), thereby expanding influenza treatment options. Favipiravir is active against a variety of additional viruses, including West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses in vitro and in vivo. Activity has also been shown against enteroviruses, Rift Valley fever virus and Marburg virus (MARV9), while limited efficacy has been shown against Ebola virus (EBOV) and Zika virus in animal studies. Favipiravir shows potential efficacy against SARS-CoV-2 and is undergoing clinical studies to test its efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19). |
T-705 (Favipiravir) |
2778-25 |
Biovision |
each |
EUR 692.4 |
T-705 (Favipiravir) |
2778-5 |
Biovision |
each |
EUR 222 |
Favorgen RNase Destroyer Sprayer |
FARND-001 |
Favorgen |
2 x sprayer & 1x sprayer head |
EUR 201.6 |
Description: - For solid waste
- Contains 2 x sprayer & 1x sprayer head/pack
|
Favorgen RNase Destroyer Sprayer |
FARND-001-1 |
Favorgen |
1 bottle/ 1L |
EUR 255.6 |
Description: - Sprayer Supplement-1 bottle/ 1L
- Package: 1 bottle in a retail box
|